Cargando…
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
Recently, there has been a growing trend in clinical development to utilize real-world data (RWD) to improve the efficiency of drug/medical device development. Especially, the use of RWD to generate real-world evidence (RWE) in regulatory approval is currently undergoing a period of great change wit...
Autores principales: | Maeda, Hideki, Ng, Daniel Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051225/ https://www.ncbi.nlm.nih.gov/pubmed/35492312 http://dx.doi.org/10.3389/fmed.2022.864960 |
Ejemplares similares
-
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective
por: Maeda, Hideki
Publicado: (2022) -
Real-World and Regulatory Perspectives of Artificial Intelligence in Cardiovascular Imaging
por: Wellnhofer, Ernst
Publicado: (2022) -
Trial designs using real‐world data: The changing landscape of the regulatory approval process
por: Baumfeld Andre, Elodie, et al.
Publicado: (2019) -
Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023) -
USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS
por: Lu, Kevin, et al.
Publicado: (2022)